147 related articles for article (PubMed ID: 27214310)
1. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
3. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
4. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
Yoshida Y; Yamagishi S; Matsui T; Jinnouchi Y; Fukami K; Imaizumi T; Yamakawa R
Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
[TBL] [Abstract][Full Text] [Related]
5. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
Matsui T; Nishino Y; Maeda S; Yamagishi S
Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
He X; Cheng R; Park K; Benyajati S; Moiseyev G; Sun C; Olson LE; Yang Y; Eby BK; Lau K; Ma JX
Kidney Int; 2017 Mar; 91(3):642-657. PubMed ID: 27914705
[TBL] [Abstract][Full Text] [Related]
9. Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.
Awad AS; Gao T; Gvritishvili A; You H; Liu Y; Cooper TK; Reeves WB; Tombran-Tink J
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F891-900. PubMed ID: 23884140
[TBL] [Abstract][Full Text] [Related]
10. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation.
Ishibashi Y; Matsui T; Ohta K; Tanoue R; Takeuchi M; Asanuma K; Fukami K; Okuda S; Nakamura K; Yamagishi S
Microvasc Res; 2013 Jan; 85():54-8. PubMed ID: 23108227
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.
Wang JJ; Zhang SX; Lu K; Chen Y; Mott R; Sato S; Ma JX
Diabetes; 2005 Jan; 54(1):243-50. PubMed ID: 15616035
[TBL] [Abstract][Full Text] [Related]
12. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex.
Che D; Fang Z; Yan L; Du J; Li F; Xie J; Feng J; Yin P; Qi W; Yang Z; Ma J; Yang X; Gao G; Zhou T
Diabetologia; 2020 Sep; 63(9):1857-1871. PubMed ID: 32377760
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX
FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model.
Lu J; Xin Z; Zhang Q; Cui D; Xiao Y; Zhuo J; Sun F; Xia S; Shao Y
Cell Tissue Res; 2016 Dec; 366(3):623-637. PubMed ID: 27655233
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
[TBL] [Abstract][Full Text] [Related]
16. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
17. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy.
Matsuoka M; Ogata N; Minamino K; Matsumura M
Mol Vis; 2007 Jun; 13():1058-65. PubMed ID: 17653050
[TBL] [Abstract][Full Text] [Related]
18. PEDF relieves kidney injury in type 2 diabetic nephropathy mice by reducing macrophage infiltration.
Li L; Zhang L; Chen D; Yu K; Gan H; Yang G
Endokrynol Pol; 2021; 72(6):643-651. PubMed ID: 34647607
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
Yamagishi S; Matsui T; Ueda S; Takeuchi M
Int J Cardiol; 2010 Oct; 144(2):283-5. PubMed ID: 19237211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]